These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 36652905)

  • 21. Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis.
    Sheng D; Jin C; Yue K; Yue M; Liang Y; Xue X; Li P; Zhao G; Zhang L
    Cancer Lett; 2024 Jun; 598():217077. PubMed ID: 38908541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer.
    Jiang Z; Zhang W; Zhang Z; Sha G; Wang D; Tang D
    Cancer Lett; 2023 Feb; 554():216031. PubMed ID: 36481214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics.
    Peng F; Hu M; Su Z; Hu L; Guo L; Yang K
    Adv Mater; 2024 Jul; ():e2405331. PubMed ID: 39054925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
    Gately S
    Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current understanding of the human microbiome in glioma.
    Liang J; Li T; Zhao J; Wang C; Sun H
    Front Oncol; 2022; 12():781741. PubMed ID: 36003766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broadening oncological boundaries: the intratumoral microbiota.
    Lu YQ; Qiao H; Tan XR; Liu N
    Trends Microbiol; 2024 Feb; ():. PubMed ID: 38310023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral microbiota is associated with prognosis in patients with adrenocortical carcinoma.
    Li Y; Zhang D; Wang M; Jiang H; Feng C; Li YX
    Imeta; 2023 May; 2(2):e102. PubMed ID: 38868430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between the lung microbiome and lung cancer.
    Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
    Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
    Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
    Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence.
    Papakonstantinou A; Nuciforo P; Borrell M; Zamora E; Pimentel I; Saura C; Oliveira M
    Cancer Treat Rev; 2022 Dec; 111():102470. PubMed ID: 36283165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unveiling the intratumoral microbiota within cancer landscapes.
    Che S; Yan Z; Feng Y; Zhao H
    iScience; 2024 Jun; 27(6):109893. PubMed ID: 38799560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Colloquy between Microbiota and the Immune System in Colon Cancer: Repercussions on the Cancer Therapy.
    Pal S; Saini AK; Kaushal A; Gupta S; Gaur NA; Chhillar AK; Sharma AK; Gupta VK; Saini RV
    Curr Pharm Des; 2022; 28(43):3478-3485. PubMed ID: 36415093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer.
    Rajpoot M; Sharma AK; Sharma A; Gupta GK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):1-8. PubMed ID: 29425888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiome in gastrointestinal cancer: a friend or foe?
    Liu Y; Baba Y; Ishimoto T; Gu X; Zhang J; Nomoto D; Okadome K; Baba H; Qiu P
    Int J Biol Sci; 2022; 18(10):4101-4117. PubMed ID: 35844804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications.
    Amara S; Yang LV; Tiriveedhi V; Muzaffar M
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intratumoral microbiome: Characterization methods and functional impact.
    Heymann CJF; Bard JM; Heymann MF; Heymann D; Bobin-Dubigeon C
    Cancer Lett; 2021 Dec; 522():63-79. PubMed ID: 34517085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiome: A Supportive or a Leading Actor in Lung Cancer?
    Martins D; Mendes F; Schmitt F
    Pathobiology; 2021; 88(2):198-207. PubMed ID: 33352574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microbiome(s) and cancer: know thy neighbor(s).
    González-Sánchez P; DeNicola GM
    J Pathol; 2021 Jul; 254(4):332-343. PubMed ID: 33723873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.